Research teams in Germany, Denmark, France and Sweden are working together to develop an antiviral treatment for the COVID-19 virus.
The consortium includes CEA, an EIT Health core partner. By developing a broad-spectrum antiviral treatment, the research will also build preparedness for future epidemics. The Fight-nCoV project received EUR 2.8 million from the European Commission to develop their treatment.
Share this page
